Laboratorios Farmaceuticos Rovi, S.A. will propose to the General Shareholders' Meeting a dividend of EUR 1.2938 per share charged to the 2022 profit and retained earnings. This proposed dividend would mean an increase of 35% on the dividend charge to the 2021 profit and represents the same 35% of the net profit for 2022 attributed to the parent company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.8 EUR | -0.57% | -3.56% | +44.19% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.19% | 4.81B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Laboratorios Farmaceuticos Rovi, S.A. Proposes Dividend for the Year 2022